title: Clinical Perspectives on Targeting Therapies for Personalized Medicine.
abstract: Expected benefits from new technology include more efficient patient selection for clinical trials, more cost-effective treatment pathways for patients and health services and a more profitable accelerated approach for drug developers. Regulatory authorities expect the pharmaceutical and biotechnology industries to accelerate their development of companion diagnostics and companion therapeutics toward the goal of safer and more effective personalized medicine, and expect health services to fund and prescribers to adopt these new therapeutic technologies. This review discusses the importance of a range of new approaches to developing new and reprofiled medicines to treat common and serious diseases, and rare diseases: new network pharmacology approaches, adaptive trial designs with enriched populations more likely to respond safely to treatment, as assessed by companion diagnostics for response and toxicity risk and use of "real world" data. Case studies are described of single and multiple protein drug targets in several important therapeutic areas. These case studies also illustrate the value and complexity of use of selective biomarkers of clinical response and risk of adverse drug effects, either singly or in combination.
authors.affiliation: Fellowship of Postgraduate Medicine, London, United Kingdom. Electronic address: fpm.chandos@gmail.com.
authors.forename: Donald R J
authors.initials: DR
authors.lastname: Singer
authors.affiliation: Warwick Medical School, University of Warwick, Coventry, United Kingdom.
authors.forename: Zoulikha M
authors.initials: ZM
authors.lastname: Zaïr
mesh_terms: D006801:Humans; D058990:Molecular Targeted Therapy; D057285:Precision Medicine
keywords: Adaptive trial design; Biosimilars; Companion diagnostic; Companion therapeutic; Network pharmacology; Pharmacogenetics; Real world data; Transporters
references.citation: Clin Cancer Res. 2015 May 1;21(9):2065-74
references.pmid: 25649019
references.citation: Clin Pharmacol Ther. 2011 Nov;90(5):701-6
references.pmid: 22012312
references.citation: Nat Biotechnol. 2007 Oct;25(10):1110-1
references.pmid: 17921993
references.citation: JAMA Psychiatry. 2013 Jan;70(1):31-41
references.pmid: 22945416
references.citation: Brain. 2002 Aug;125(Pt 8):1887-95
references.pmid: 12135978
references.citation: Brain Behav Immun. 2013 Jul;31:90-5
references.pmid: 22749891
references.citation: Biomed Pharmacother. 2011 Sep;65(6):417-26
references.pmid: 21719246
references.citation: Annu Rev Pharmacol Toxicol. 2005;45:89-118
references.pmid: 15822172
references.citation: Ann N Y Acad Sci. 2015 Sep;1351:68-79
references.pmid: 25943397
references.citation: Brain. 2014 Aug;137(Pt 8):2178-92
references.pmid: 24951641
references.citation: Leukemia. 2009 Jun;23(6):1054-61
references.pmid: 19282833
references.citation: Chin Clin Oncol. 2014 Jun;3(2):21
references.pmid: 25841417
references.citation: N Engl J Med. 2015 Jul 16;373(3):220-31
references.pmid: 25981758
references.citation: Biochim Biophys Acta. 2010 Mar;1804(3):445-53
references.pmid: 19922818
references.citation: Epidemiology. 2016 Jan;27(1):133-42
references.pmid: 26436519
references.citation: Expert Rev Vaccines. 2014 Nov;13(11):1339-48
references.pmid: 25066368
references.citation: Blood. 2014 Oct 9;124(15):2408-10
references.pmid: 25170123
references.citation: J Clin Oncol. 2016 Jan 20;34(3):244-50
references.pmid: 26527782
references.citation: J Clin Oncol. 1999 Jan;17(1):434
references.pmid: 10458264
references.citation: Clin Cancer Res. 2012 Jun 15;18(12):3478-86
references.pmid: 22504044
references.citation: BMJ. 2013 Nov 11;347:f6409
references.pmid: 24217206
references.citation: Cochrane Database Syst Rev. 2014 Jun 12;(6):CD006242
references.pmid: 24919460
references.citation: N Engl J Med. 2013 Apr 4;368(14):1272-4
references.pmid: 23484796
references.citation: J Biopharm Stat. 2014;24(1):168-87
references.pmid: 24392984
references.citation: JAMA. 2012 Mar 28;307(12):1265-72
references.pmid: 22453568
references.citation: Nat Rev Genet. 2011 Jan;12(1):56-68
references.pmid: 21164525
references.citation: N Engl J Med. 2008 Aug 21;359(8):789-99
references.pmid: 18650507
references.citation: Psychol Med. 2015 Dec;45(16):3481-9
references.pmid: 26243040
references.citation: Kidney Int. 2012 Apr;81(8):727-32
references.pmid: 22336988
references.citation: Clin Pharmacol Ther. 2014 Jul;96(1):15-7
references.pmid: 24942396
references.citation: Vascul Pharmacol. 2007 Oct;47(4):199-208
references.pmid: 17804301
references.citation: Drug Metab Pharmacokinet. 2013;28(1):4-18
references.pmid: 23047721
references.citation: J Clin Oncol. 2008 Apr 1;26(10):1626-34
references.pmid: 18316791
references.citation: Acta Neuropathol. 2010 Sep;120(3):327-41
references.pmid: 20640903
references.citation: Br J Cancer. 2015 Aug 11;113(4):569-73
references.pmid: 26158421
references.citation: Circ Res. 2007 Jan 5;100(1):50-60
references.pmid: 17158337
references.citation: Nat Chem Biol. 2008 Nov;4(11):682-90
references.pmid: 18936753
references.citation: Blood. 2014 Feb 27;123(9):1353-60
references.pmid: 24335106
references.citation: PLoS One. 2013 Oct 15;8(10):e77223
references.pmid: 24143213
references.citation: Am J Physiol Lung Cell Mol Physiol. 2014 Sep 15;307(6):L431-4
references.pmid: 25063802
references.citation: Br J Cancer. 2011 Nov 8;105(10):1495-502
references.pmid: 21989186
references.citation: BioDrugs. 2014 Aug;28(4):363-72
references.pmid: 24567263
references.citation: Blood. 2009 Feb 19;113(8):1619-30
references.pmid: 18827185
references.citation: Brain. 2002 Jan;125(Pt 1):166-75
references.pmid: 11834602
references.citation: J Clin Oncol. 2006 Nov 1;24(31):5034-42
references.pmid: 17075123
references.citation: Eur J Cancer. 2013 Mar;49(5):1027-31
references.pmid: 23140824
references.citation: Pharmacogenomics. 2008 May;9(5):597-624
references.pmid: 18466105
references.citation: N Engl J Med. 2011 Jun 30;364(26):2507-16
references.pmid: 21639808
references.citation: Mol Biosyst. 2009 Dec;5(12):1536-48
references.pmid: 19763339
references.citation: Trends Pharmacol Sci. 2010 Mar;31(3):115-23
references.pmid: 20117850
references.citation: PLoS One. 2011;6(8):e23112
references.pmid: 21826230
references.citation: Essays Biochem. 2011 Sep 7;50(1):1-17
references.pmid: 21967049
references.citation: Science. 2004 Jul 23;305(5683):525-8
references.pmid: 15273396
references.citation: PLoS One. 2015 Aug 12;10(8):e0134398
references.pmid: 26267891
references.citation: Soc Psychiatry Psychiatr Epidemiol. 2014 Jun;49(6):841-9
references.pmid: 24789456
references.citation: Chem Commun (Camb). 2007 Jul 19;(27):2808-10
references.pmid: 17609783
references.citation: Atherosclerosis. 2011 Mar;215(1):1-8
references.pmid: 21130454
references.citation: Lancet Psychiatry. 2015 Mar;2(3):258-270
references.pmid: 26359903
references.citation: Pharmacol Rev. 2011 Mar;63(1):157-81
references.pmid: 21245207
references.citation: Cell Cycle. 2005 Jan;4(1):87-95
references.pmid: 15611642
references.citation: Lancet. 2010 Feb 27;375(9716):735-42
references.pmid: 20167359
references.citation: Pharmacogenet Genomics. 2006 Aug;16(8):565-8
references.pmid: 16847425
references.citation: ChemMedChem. 2008 May;3(5):742-4
references.pmid: 18241077
references.citation: Pharmacogenomics. 2002 Jan;3(1):89-98
references.pmid: 11966406
references.citation: Cancer. 2009 Apr 1;115(7):1544-54
references.pmid: 19189371
references.citation: Am J Cardiol. 1996 Dec 15;78(12):1453-6
references.pmid: 8970428
references.citation: Int J Cancer. 2016 Jan 15;138(2):320-31
references.pmid: 26219435
references.citation: Blood. 2011 Aug 4;118(5):1208-15
references.pmid: 21562040
references.citation: Stat Med. 2016 Mar 15;35(6):840-58
references.pmid: 26412033
references.citation: Chem Commun (Camb). 2013 Oct 25;49(83):9588-90
references.pmid: 24019076
references.citation: Psychol Med. 2012 Sep;42(9):1893-901
references.pmid: 22260948
references.citation: Pharmacogenet Genomics. 2011 Aug;21(8):506-15
references.pmid: 21691255
references.citation: Clin Pharmacol Ther. 2014 Apr;95(4):376-82
references.pmid: 24458010
references.citation: Cancer Treat Rev. 2015 Dec;41(10):859-67
references.pmid: 26547132
references.citation: Ther Deliv. 2010 Nov;1(5):651-65
references.pmid: 22833955
references.citation: Stat Med. 2016 Apr 15;35(8):1257-66
references.pmid: 26526165
references.citation: Acta Pharmacol Sin. 2005 Jun;26(6):696-704
references.pmid: 15916736
references.citation: Pharmacogenomics. 2012 Aug;13(11):1285-306
references.pmid: 22920398
references.citation: J Clin Oncol. 2011 May 20;29(15):2011-9
references.pmid: 21502544
references.citation: J Biomed Inform. 2015 Dec;58:247-259
references.pmid: 26515501
references.citation: PLoS Biol. 2010 Dec 21;8(12):e1000563
references.pmid: 21203579
references.citation: Cardiovasc Res. 2013 Jul 1;99(1):44-54
references.pmid: 23542580
references.citation: Cancer Res. 2007 Nov 15;67(22):11012-20
references.pmid: 18006847
references.citation: N Engl J Med. 2012 Jan 12;366(2):109-19
references.pmid: 22149875
references.citation: Brain. 2004 Mar;127(Pt 3):701-12
references.pmid: 14960497
references.citation: Lancet Oncol. 2015 May;16(5):550-60
references.pmid: 25882987
references.citation: Curr Pharm Des. 2010;16(2):220-30
references.pmid: 19835554
references.citation: N Engl J Med. 2003 Mar 13;348(11):994-1004
references.pmid: 12637609
references.citation: Brain. 2015 Nov;138(Pt 11):3159-67
references.pmid: 26373601
references.citation: Int J Clin Exp Med. 2015 Jan 15;8(1):334-45
references.pmid: 25785004
references.citation: Blood. 2013 Jun 13;121(24):4867-74
references.pmid: 23620574
references.citation: Cancer Res. 2012 Feb 1;72(3):779-89
references.pmid: 22180495
references.citation: J Pharmacol Exp Ther. 2013 Apr;345(1):95-101
references.pmid: 23386248
references.citation: JAMA. 2010 Oct 27;304(16):1821-30
references.pmid: 20978260
references.citation: Nat Clin Pract Oncol. 2007 Sep;4(9):536-50
references.pmid: 17728712
references.citation: Mol Cell. 2015 May 21;58(4):690-8
references.pmid: 26000852
references.citation: N Engl J Med. 1989 Aug 10;321(6):406-12
references.pmid: 2473403
references.citation: Neurology. 2015 May 26;84(21):2161-8
references.pmid: 25934853
references.citation: Nat Rev Drug Discov. 2009 Apr;8(4):279-86
references.pmid: 19300459
references.citation: Food Drug Law J. 2015;70(2):289-314, ii-iii
references.pmid: 26302601
references.citation: Nature. 1990 Feb 1;343(6257):425-30
references.pmid: 1967820
references.citation: Mol Psychiatry. 2016 May;21(5):642-9
references.pmid: 26033244
references.citation: Blood. 2014 Apr 10;123(15):2317-24
references.pmid: 24569263
references.citation: Cancer. 2015 Mar 15;121(6):863-71
references.pmid: 25387866
references.citation: Atherosclerosis. 2010 Jun;210(2):337-43
references.pmid: 20042189
references.citation: Blood. 2010 Nov 11;116(19):3758-65
references.pmid: 20679528
references.citation: J Drug Deliv. 2013;2013:863539
references.pmid: 23431456
references.citation: Schizophr Bull. 2015 Sep;41(5):1162-70
references.pmid: 25829375
references.citation: JAMA. 2015 Jan 13;313(2):131-2
references.pmid: 25585318
references.citation: J Pharmacol Exp Ther. 2015 Sep;354(3):358-75
references.pmid: 26148856
references.citation: Lancet Oncol. 2015 Jul;16(7):859-70
references.pmid: 26095784
references.citation: Xenobiotica. 2013 Oct;43(10):920-31
references.pmid: 23461378
references.citation: Ther Drug Monit. 2015 Aug;37(4):501-7
references.pmid: 26192892
references.citation: Pharmgenomics Pers Med. 2011;4:1-9
references.pmid: 23226050
references.citation: Pharm Res. 2014 Jan;31(1):204-15
references.pmid: 23921491
references.citation: J Clin Oncol. 2015 Jul 20;33(21):2384-91
references.pmid: 26077237
references.citation: Per Med. 2012 Sep;9(7):751-761
references.pmid: 29776269
references.citation: Nat Biotechnol. 2009 Feb;27(2):110-2
references.pmid: 19204679
references.citation: J Immunol. 2011 Jun 15;186(12):7215-24
references.pmid: 21572034
references.citation: Mol Pharmacol. 2004 Jun;65(6):1485-95
references.pmid: 15155841
references.citation: Physiol Res. 2012;61 Suppl 2:S33-41
references.pmid: 23130901
references.citation: Proc Natl Acad Sci U S A. 1986 Nov;83(21):8370-4
references.pmid: 3464957
references.citation: N Engl J Med. 2009 Sep 17;361(12):1139-51
references.pmid: 19717844
references.citation: Cancer Lett. 2014 Aug 28;351(1):30-40
references.pmid: 24943493
references.citation: N Engl J Med. 2011 Oct 6;365(14):1273-83
references.pmid: 21991949
references.citation: Blood. 2015 Aug 6;126(6):746-56
references.pmid: 26065651
references.citation: Lancet Oncol. 2014 Mar;15(3):323-32
references.pmid: 24508103
references.citation: Jpn J Clin Oncol. 2015 Nov;45(11):1082-6
references.pmid: 26355164
references.citation: Apoptosis. 2010 Jun;15(6):669-78
references.pmid: 20151195
references.citation: Cancer Sci. 2005 Aug;96(8):457-65
references.pmid: 16108826
references.citation: J Cardiol. 2009 Jun;53(3):402-9
references.pmid: 19477383
references.citation: Am J Hematol. 2015 Sep;90(9):819-24
references.pmid: 26103598
references.citation: Mol Aspects Med. 2013 Apr-Jun;34(2-3):396-412
references.pmid: 23506880